Recombinant human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 from mouse myeloma cell

Cat. No.: X23-06-YM258

Recombinant human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 from mouse myeloma cell

Synonym: ST3GAL3

Product Size
20 μg; 100 μg; 200 μg
Price
Datasheet
MSDS
Properties
Description
Recombinant human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 from mouse myeloma cell plays a key role in the synthesis of both sialyl Lewis x (sLex) and sialyl Lewis a (sLea) epitopes that can serve as the ligands for E- and P-selectins on activated endothelial cells in inflammation.
Molecular Weight
37-43 kDa
Source
Mouse myeloma cell
Form
Solution
Purity
>90%, determined by SDS-PAGE.
Applications
Recombinant human ST3 beta-galactoside alpha-2,3-sialyltransferase 3 from mouse myeloma cell is useful for the investigation of autosomal recessive nonsyndromic cognitive disability.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0